Serum Sclerostin Levels in Patients with Human Immunodeficiency Virus Infection and Their Association with Bone Turnover Markers and Bone Mineral Densitometry
Abdulrahman Y. Almansouri, Mohammed E. Abdulfatah, Omar H. Baaqil, Alaa A. Bakheet, Sarah A. Turki, Mamdouh M. Kotb, Alaa Althubaiti, Majed M. Almaghrabi, Abdulrahman M. Althubaiti, Badr M. Madani, Ali S. M. Jawad
J Bone Metab. 2016;23(1):16-22.   Published online 2016 Feb 29     DOI: https://doi.org/10.11005/jbm.2016.23.1.16
Citations to this article as recorded by Crossref logo
Evaluation of the relationship between inflammation and bone turnover by sclerostin and Dickkopf-1 (DKK-1) levels in patients with SIRS
Hatice Betül ALTINIŞIK, Uğur ALTINIŞIK, Mehmet AŞIK
Family Practice and Palliative Care.2022; 7(3): 77.     CrossRef
Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus
Ryan D. Ross, Anjali Sharma, Qiuhu Shi, Donald R. Hoover, Kathleen M. Weber, Phyllis C. Tien, Audrey L. French, Lena Al-Harthi, Michael T. Yin
Bone Reports.2020; 12: 100279.     CrossRef
Increase in bone turnover markers in HIV patients treated with tenofovir disoproxil fumarate combined with raltegravir or efavirenz
Yonatan Oster, Matan J. Cohen, Rivka Dresner-Pollak, Auryan Szalat, Hila Elinav
Bone Reports.2020; 13: 100727.     CrossRef
Abdominal obesity, sarcopenia, and osteoporosis are associated with frailty in men living with and without HIV
Kellie L. Hawkins, Long Zhang, Derek K. Ng, Keri N. Althoff, Frank J. Palella, Lawrence A. Kingsley, Lisa P. Jacobson, Joseph B. Margolick, Jordan E. Lake, Todd T. Brown, Kristine M. Erlandson
AIDS.2018; 32(10): 1257.     CrossRef
Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection
Mariska C. Vlot, Marlous L. Grijsen, Jan M. Prins, Renate T. de Jongh, Robert de Jonge, Martin den Heijer, Annemieke C. Heijboer, Giuseppe Vittorio De Socio
PLOS ONE.2018; 13(3): e0193679.     CrossRef
Clinical Utility of Biochemical Marker of Bone Turnover: Fracture Risk Prediction and Bone Healing
Byung-Ho Yoon, Woojin Yu
Journal of Bone Metabolism.2018; 25(2): 73.     CrossRef
Control of Bone Homeostasis by the Wnt Inhibitor Sclerostin
Meghan E. McGee-Lawrence, Mark W. Hamrick
Current Molecular Biology Reports.2016; 2(3): 141.     CrossRef